PV pharm branch, vendor, cage 0U9U0

Ended Awarded

Contract number
SPE2D826FAB7C
Awardee
Awarding agency
Obligated
$13,817

Award facts

Contract value 100% obligated
$13,817.42 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

This delivery order, awarded November 3, 2025, represents a $13,817.42 firm fixed-price award to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal procurement organization. The contract is a non-set-aside, competitively awarded delivery order with a completion date of November 4, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical federal medical procurement needs through its comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's track record with DLA demonstrates consistent capability to deliver across multiple therapeutic domains on a competitive basis, with prior delivery orders ranging from minimal amounts to over $45,000. As a primary vendor supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, AmerisourceBergen maintains strategic positioning in the federal pharmaceutical supply chain, with DLA planning future regional expansion of its Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple contractors.

Quick answers

Who was awarded contract SPE2D826FAB7C?

SPE2D826FAB7C was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on November 3, 2025.

How much is contract SPE2D826FAB7C worth?

The government has obligated $13,817 on SPE2D826FAB7C.

Is contract SPE2D826FAB7C an order under another contract?

Yes. SPE2D826FAB7C is a delivery order under SPE2DX22D0099, an indefinite delivery contract.

Was contract SPE2D826FAB7C competed?

The extent of competition for SPE2D826FAB7C was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award